Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global atrial fibrillation treatment market grew at a CAGR of around 14% during 2014-2019. Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further. Looking forward, IMARC Group expects the market to continue its strong growth during the next five years.

Breakup by Disorder Type:

Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Others

Breakup by Treatment Type:

Medical Procedures
Surgical Procedures
Maze Surgery
Catheter Ablation
Non-Surgical Procedures
Electric Cardioversion
Diagnostic Catheters
Mapping and Recording Systems
Cardiac Monitors
Access Devices
Left Atrial Appendage and Closure Devices
Intracardiac Echocardiography (ICE) Systems
Medication
Anticoagulants
Anti-Arrhythmics

Breakup by End-User:

Hospitals
Cardiac Labs
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers (Cerner Corporation), Stereotaxis Inc., etc.

Key Questions Answered in This Report:

How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the disorder type?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global atrial fibrillation market treatment and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Atrial Fibrillation Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Disorder Type
6.1 Paroxysmal Atrial Fibrillation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Persistent Atrial Fibrillation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Permanent Atrial Fibrillation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Medical Procedures
7.1.1 Market Trends
7.1.2 Surgical Procedures
7.1.2.1 Maze Surgery
7.1.2.2 Catheter Ablation
7.1.3 Non-Surgical Devices
7.1.3.1 Electric Cardioversion
7.1.3.2 Diagnostic Catheters
7.1.3.3 Mapping and Recording Systems
7.1.3.4 Cardiac Monitors
7.1.3.5 Access Devices
7.1.3.6 Left Atrial Appendage and Closure Devices
7.1.3.7 Intracardiac Echocardiography (ICE) Systems
7.1.4 Market Forecast
7.2 Medications
7.2.1 Market Trends
7.2.2 Drug Classes
7.2.2.1 Anticoagulants
7.2.2.2 Anti-Arrhythmics
7.2.3 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Atricure Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biosense Webster Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Biotronik
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Cardiofocus Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Hansen Medical Inc. (Auris Health)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Siemens Healthineers (Cerner Corporation)
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Stereotaxis Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
List of Figures
Figure 1: Global: Atrial Fibrillation Market: Major Drivers and Challenges
Figure 2: Global: Atrial Fibrillation Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Atrial Fibrillation Market: Breakup by Disorder Type (in %), 2019
Figure 4: Global: Atrial Fibrillation Market: Breakup by Treatment Type (in %), 2019
Figure 5: Global: Atrial Fibrillation Market: Breakup by End-User (in %), 2019
Figure 6: Global: Atrial Fibrillation Market: Breakup by Region (in %), 2019
Figure 7: Global: Atrial Fibrillation Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Atrial Fibrillation (Medical Procedures) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Atrial Fibrillation Market (Medical Procedures): Breakup by Type (in %), 2019
Figure 18: Global: Atrial Fibrillation Market (Surgical Procedures): Breakup by Type (in %), 2019
Figure 19: Global: Atrial Fibrillation (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Atrial Fibrillation (Medication) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Atrial Fibrillation Market (Medication): Breakup by Drug Class (in %), 2019
Figure 22: Global: Atrial Fibrillation (Medication) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Atrial Fibrillation (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Atrial Fibrillation (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Atrial Fibrillation (Cardiac Labs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Atrial Fibrillation (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: North America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: North America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: United States: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: United States: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Canada: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Canada: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Asia Pacific: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Asia Pacific: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: China: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: China: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Japan: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Japan: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: India: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: India: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: South Korea: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: South Korea: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Australia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Australia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Indonesia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Indonesia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Europe: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Europe: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Germany: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Germany: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: France: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: France: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: United Kingdom: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: United Kingdom: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Italy: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Italy: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Spain: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Spain: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Russia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Russia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Latin America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Latin America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Brazil: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Brazil: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Mexico: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Mexico: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Middle East and Africa: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Middle East and Africa: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Global: Atrial Fibrillation Industry: SWOT Analysis
Figure 80: Global: Atrial Fibrillation Industry: Value Chain Analysis
Figure 81: Global: Atrial Fibrillation Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Atrial Fibrillation Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Atrial Fibrillation Market Forecast: Breakup by Devices (in Million US$), 2020-2025
Table 3: Global: Atrial Fibrillation Market Forecast: Breakup by Drug Class (in Million US$), 2020-2025
Table 4: Global: Atrial Fibrillation Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 5: Global: Atrial Fibrillation Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 6: Global: Atrial Fibrillation Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Atrial Fibrillation Market Structure
Table 8: Global: Atrial Fibrillation Market: Key Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook